immunotherapyanti-angiogenic therapyNSCLCnon-small cell lung cancertucidinostat
…e retrospectively analyzed 141 patients with NSCLC who received immunotherapy, including 9 monoimmunotherapy and 132 immunotherapy plus chemo…
2articles mentioning treatments
2treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: anti-angiogenic therapy ×
anti-angiogenic therapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning anti-angiogenic therapy
2 articles · page 1 of 176.8%
anti-angiogenic therapyfaricimabAfliberceptbevacizumabAge-related macular degeneration (AMD)
…sponsible for 90% of cases of severe vision loss, benefits from anti-angiogenic therapy, mainly aflibercept and bevacizumab, with faricimab as a second…